202 0 653 17 3863 ± 6 67757 0 808* 0 370    No 7 30     18 4865 ±

202 0.653 17.3863 ± 6.67757 0.808* 0.370    No 7 30     18.4865 ± 6.97671     Alcohol consumption     0.608 0.436   0.008* 0.927    Yes 22 69     17.5388 ± 6.43099        No 22 90     17.6259 ± 6.99013     Location     2.213 0.331   3.550 0.031    Super glottic 24 69     18.2441 ± 7.14615        glottic 18 75     16.3786 ± 5.94319        subglottic 2 15     20.3667 ± 7.35727     pTNM LY3023414     6.570 0.010   7.419* 0.007    I+II 11 74     16.0306 ± 6.19107        III+IV 33 85     18.5977 ± 6.91980     Tumor size (cm)     0.220 0.639   0.974* 0.325    ≥3 20 66  

  18.1306 ± 6.22807        >3 24 93     17.1872 ± 7.07416     T stage     1.278 0.734   3.396 0.019    T1 6 21     13.8593 ± 5.61853        T2 17 76     17.7731 ± 6.43417        T3 11 33     17.9143 ± 6.69789        T4 10 29     18.8667 ± 7.50099     Nodal status     9.097 0.003   0.019* 0.892 N-positive (N1, N2, N3) 19 33     17.4769 ± 6.50208        N-negative(N0) 25 126     17.6247 ± 6.82606     Distant metastasis     1.535 0.215   4.077* 0.045    Yes 2 17     20.4684 ± 6.86740        No 42 142     17.2186 ± 6.65992     Recurrence     0.005 0.994   0.679* 0.498    Yes 7 26     18.3152 ± 6.59413        No 37 133     17.4455 ± 6.76481     Histopathological grade     15.531 0.000   0.209 0.811    1 2 28     16.8967 ± 5.69443        2 30 119     17.7532

± 7.12289        3 12 12     17.4167 ± 5.42896     VM: vasculogenic selleck compound mimicry; EDV: endothelial dependent vessel; LSCC: laryngeal squamous cell carcinoma; TNM: tumor, node, metastasis. We performed immunohistochemical staining for CD31, a classic endothelial cell marker, to label endothelial dependent vessel, and analyzed whether it was associated with tumor clinicopathologic characteristic. The results showed MVD was correlated to location (p = 0.031), pTNM stage (p = 0.007), T stage (p = 0.019) and distant metastasis (p = 0.045). While, showed no

association between MVD and gender, age, tobacco use, alcohol consumption, tumor size, lymph node metastasis, recurrence or histopathological grade (all P > 0.05). Survival analysis Univariate analysis showed that survival of VM-positive patients was significantly poorer than that of VM-negative patients in OS (p = 0.014) (Fig. 2A). Furthermore, Interleukin-2 receptor pTNM stage (P = 0.009), T classification (P = 0.013), nodal status (P = 0.013), and histopathological grade (P = 0.038), tumor size (P = 0.028), radiotherapy (P < 0.0001) correlated with OS. However, there was no significant association between OS and gender, age at diagnosis, tobacco use, alcohol consumption, location, distant metastasis, recurrence and MVD (Fig. 2B) (all P > 0.05; Table 2). Multivariate analysis indicated that the presence of VM (risk ratio (RR) = -2.117, P = 0.003), recurrence (RR = -1.821, P = 0.020) and pTNM stage (RR = 1.367, P = 0.009) were adverse predictors for OS (Table 3), while radiotherapy were indicators of a good prognosis of OS (RR = 2.872, P < 0.0001).

Comments are closed.